当前位置：
X-MOL 学术
›
Aliment. Pharm. Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Editorial: Is it time to include oral vancomycin in therapeutic guidelines for primary sclerosing cholangitis‐associated inflammatory bowel disease?
Alimentary Pharmacology & Therapeutics ( IF 7.6 ) Pub Date : 2024-04-23 , DOI: 10.1111/apt.17990 Ayesha Shah 1 , Gerald Holtmann 1
Alimentary Pharmacology & Therapeutics ( IF 7.6 ) Pub Date : 2024-04-23 , DOI: 10.1111/apt.17990 Ayesha Shah 1 , Gerald Holtmann 1
Affiliation
LINKED CONTENTThis article is linked to Ricciuto et al paper. To view this article, visit https://doi.org/10.1111/apt.17936
中文翻译：
社论：是时候将口服万古霉素纳入原发性硬化性胆管炎相关炎症性肠病的治疗指南了吗？
链接内容本文链接到 Ricciuto 等人的论文。要查看这篇文章，请访问https://doi.org/10.1111/apt.17936
更新日期：2024-04-23
中文翻译：
社论：是时候将口服万古霉素纳入原发性硬化性胆管炎相关炎症性肠病的治疗指南了吗？
链接内容本文链接到 Ricciuto 等人的论文。要查看这篇文章，请访问
京公网安备 11010802027423号